In a double-blind, randomized, crossover, euglycemic glucose clamp study, fifty eight healthy male subjects between 19 and 50 years of age received an intravenous infusion of either MYXREDLIN or another human insulin at 1 milliUnit/kg/min for 6 hours (0.36 units/kg total dose). On average...
申请类型 BLA 申请号 208157 药品名称 MYXREDLIN 活性成分 INSULIN HUMAN 活性成分中文 暂无权限 执行时间 2020-03-23 持有公司 BAXTER HLTHCARE CORP 说明书 下载 扩展信息 VIP试用医疗器械查询APP下载客服中心常见问题数据可视化数据分析挖掘系统网站地图业务介绍友情链接 400-678-0778 投诉...
Safety Alert: Look-Alike Errors with Myxredlin.doi:10.1097/01.NAJ.0001081716.52331.0dAschenbrenner, Diane S. MS, RNWolters Kluwer Health, Inc.AJN, American Journal of Nursing
dyspnea, wheezing, hypotension, tachycardia, or diaphoresis. If hypersensitivity reactions occur, discontinue MYXREDLIN; treat per standard of care and monitor until symptoms and signs resolve. MYXREDLIN is contraindicated